Suppr超能文献

腺苷酸活化蛋白激酶与癌症。

AMP-activated protein kinase and cancer.

机构信息

Department of Pharmacology and Moores Cancer Center, University of California at San Diego, La Jolla, CA 92093, USA.

出版信息

Acta Physiol (Oxf). 2009 May;196(1):55-63. doi: 10.1111/j.1748-1716.2009.01980.x. Epub 2009 Feb 25.

Abstract

AMP-activated protein kinase (AMPK) is a cellular energy sensor that is conserved in eukaryotes. Elevated AMP/ATP ratio activates AMPK, which inhibits energy-consuming processes and activates energy-producing processes to restore the energy homeostasis inside the cell. AMPK activators, metformin and thiazolidinediones, are used for the treatment of type II diabetes. Recently, reports have indicated that AMPK may also be a beneficial target for cancer treatment. Cancer cells have characteristic metabolic changes different from normal cells and, being a key metabolic regulator, AMPK may regulate the switch. AMPK may act to inhibit tumorigenesis through regulation of cell growth, cell proliferation, autophagy, stress responses and cell polarity.

摘要

腺苷酸活化蛋白激酶 (AMPK) 是一种在真核生物中保守的细胞能量传感器。升高的 AMP/ATP 比值会激活 AMPK,它会抑制耗能过程,激活产能过程,以恢复细胞内的能量平衡。AMPK 激活剂二甲双胍和噻唑烷二酮类药物被用于治疗 2 型糖尿病。最近的报道表明,AMPK 也可能是癌症治疗的一个有益靶点。癌细胞具有不同于正常细胞的特征性代谢变化,而 AMPK 作为关键的代谢调节剂,可能调节这种变化。AMPK 可能通过调节细胞生长、细胞增殖、自噬、应激反应和细胞极性来抑制肿瘤发生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验